

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.05355970 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.05355970 |
| 3 | endothelial cell chemotaxis (GO:0035767) | 4.84367972 |
| 4 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.80221819 |
| 5 | response to peptidoglycan (GO:0032494) | 4.66204163 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.46863722 |
| 7 | positive thymic T cell selection (GO:0045059) | 4.43782741 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 4.35360382 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.20652466 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.14012011 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.12350945 |
| 12 | detection of other organism (GO:0098543) | 4.05732201 |
| 13 | cellular extravasation (GO:0045123) | 3.98864122 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 3.90401039 |
| 15 | detection of molecule of bacterial origin (GO:0032490) | 3.90074610 |
| 16 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.89977403 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.85473825 |
| 18 | positive T cell selection (GO:0043368) | 3.79865776 |
| 19 | detection of bacterium (GO:0016045) | 3.79816695 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.77626245 |
| 21 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.70105995 |
| 22 | response to muramyl dipeptide (GO:0032495) | 3.63459934 |
| 23 | detection of external biotic stimulus (GO:0098581) | 3.61894794 |
| 24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.61140749 |
| 25 | neutrophil activation (GO:0042119) | 3.53651626 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.50929952 |
| 27 | cellular response to nicotine (GO:0071316) | 3.48592115 |
| 28 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.48516493 |
| 29 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.47968484 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.46461993 |
| 31 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.43106121 |
| 32 | thymic T cell selection (GO:0045061) | 3.42177520 |
| 33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.41382056 |
| 34 | granulocyte activation (GO:0036230) | 3.40067438 |
| 35 | neutrophil mediated immunity (GO:0002446) | 3.34661000 |
| 36 | detection of biotic stimulus (GO:0009595) | 3.32429018 |
| 37 | tolerance induction (GO:0002507) | 3.29447047 |
| 38 | response to interleukin-15 (GO:0070672) | 3.28350141 |
| 39 | NIK/NF-kappaB signaling (GO:0038061) | 3.27734481 |
| 40 | modulation by symbiont of host cellular process (GO:0044068) | 3.25870825 |
| 41 | leukocyte aggregation (GO:0070486) | 3.24899643 |
| 42 | modulation by virus of host process (GO:0019054) | 3.23272576 |
| 43 | defense response to protozoan (GO:0042832) | 3.22492389 |
| 44 | endoderm formation (GO:0001706) | 3.21312382 |
| 45 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.20466916 |
| 46 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.20254180 |
| 47 | response to host immune response (GO:0052572) | 3.20254180 |
| 48 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.19121729 |
| 49 | macrophage activation (GO:0042116) | 3.17859968 |
| 50 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.12327734 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 3.11084225 |
| 52 | regulation of vitamin metabolic process (GO:0030656) | 3.09055053 |
| 53 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.08223475 |
| 54 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.07745504 |
| 55 | activated T cell proliferation (GO:0050798) | 3.06918956 |
| 56 | response to host (GO:0075136) | 3.05607709 |
| 57 | response to host defenses (GO:0052200) | 3.05607709 |
| 58 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.05607709 |
| 59 | histone H3-K4 trimethylation (GO:0080182) | 3.04763838 |
| 60 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.04606787 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.03952369 |
| 62 | T cell selection (GO:0045058) | 3.02118070 |
| 63 | response to type I interferon (GO:0034340) | 3.01922124 |
| 64 | type I interferon signaling pathway (GO:0060337) | 3.01788787 |
| 65 | cellular response to type I interferon (GO:0071357) | 3.01788787 |
| 66 | interferon-gamma production (GO:0032609) | 3.01486219 |
| 67 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.01097699 |
| 68 | response to protozoan (GO:0001562) | 2.99621492 |
| 69 | regulation of mast cell degranulation (GO:0043304) | 2.98171226 |
| 70 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.96762553 |
| 71 | negative regulation of interleukin-6 production (GO:0032715) | 2.95328970 |
| 72 | respiratory burst (GO:0045730) | 2.95094476 |
| 73 | myeloid cell activation involved in immune response (GO:0002275) | 2.94730066 |
| 74 | T-helper 1 type immune response (GO:0042088) | 2.92870370 |
| 75 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.90969048 |
| 76 | regulation of interleukin-13 production (GO:0032656) | 2.88658028 |
| 77 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.87265702 |
| 78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87097670 |
| 79 | positive regulation of interleukin-2 production (GO:0032743) | 2.85531793 |
| 80 | regulation of fever generation (GO:0031620) | 2.84326724 |
| 81 | myeloid leukocyte mediated immunity (GO:0002444) | 2.84096894 |
| 82 | regulation of immunoglobulin secretion (GO:0051023) | 2.83820807 |
| 83 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.82695961 |
| 84 | cellular response to interleukin-15 (GO:0071350) | 2.81807023 |
| 85 | microglial cell activation (GO:0001774) | 2.81114523 |
| 86 | regulation of tolerance induction (GO:0002643) | 2.80420160 |
| 87 | myeloid dendritic cell differentiation (GO:0043011) | 2.80406007 |
| 88 | positive regulation of heat generation (GO:0031652) | 2.79203532 |
| 89 | negative regulation of type 2 immune response (GO:0002829) | 2.79032743 |
| 90 | positive regulation of interleukin-17 production (GO:0032740) | 2.78411554 |
| 91 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.76872934 |
| 92 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.75602453 |
| 93 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.75602453 |
| 94 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.74707586 |
| 95 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.74707586 |
| 96 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.74707586 |
| 97 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.74698737 |
| 98 | T-helper cell differentiation (GO:0042093) | 2.74698737 |
| 99 | negative thymic T cell selection (GO:0045060) | 2.71622610 |
| 100 | negative T cell selection (GO:0043383) | 2.71449253 |
| 101 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.70978610 |
| 102 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.70371668 |
| 103 | regulation of leukocyte degranulation (GO:0043300) | 2.69967464 |
| 104 | facial nerve structural organization (GO:0021612) | 2.67984762 |
| 105 | positive regulation of astrocyte differentiation (GO:0048711) | 2.67047181 |
| 106 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.66465084 |
| 107 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.65943100 |
| 108 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.64853470 |
| 109 | negative regulation of interleukin-12 production (GO:0032695) | 2.64773813 |
| 110 | skeletal muscle cell differentiation (GO:0035914) | 2.64120355 |
| 111 | ear development (GO:0043583) | 2.64069636 |
| 112 | neutrophil chemotaxis (GO:0030593) | 2.64007149 |
| 113 | positive regulation of type 2 immune response (GO:0002830) | 2.63119238 |
| 114 | response to laminar fluid shear stress (GO:0034616) | 2.62304692 |
| 115 | regulation of regulatory T cell differentiation (GO:0045589) | 2.62157457 |
| 116 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.60888252 |
| 117 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.59484749 |
| 118 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.59358721 |
| 119 | regulation of p38MAPK cascade (GO:1900744) | 2.58437102 |
| 120 | positive regulation of tolerance induction (GO:0002645) | 2.58376169 |
| 121 | neutrophil migration (GO:1990266) | 2.56715090 |
| 122 | regulation of type 2 immune response (GO:0002828) | 2.56474982 |
| 123 | B cell receptor signaling pathway (GO:0050853) | 2.54837104 |
| 124 | negative regulation of innate immune response (GO:0045824) | 2.53192293 |
| 125 | alpha-beta T cell differentiation (GO:0046632) | 2.53133754 |
| 126 | T cell receptor signaling pathway (GO:0050852) | 2.52507353 |
| 127 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.51445739 |
| 128 | myeloid leukocyte activation (GO:0002274) | 2.50902498 |
| 129 | positive regulation of interleukin-4 production (GO:0032753) | 2.50733135 |
| 130 | T cell differentiation involved in immune response (GO:0002292) | 2.50705000 |
| 131 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.50705000 |
| 132 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.50705000 |
| 133 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.50117897 |
| 134 | positive regulation of isotype switching (GO:0045830) | 2.49742185 |
| 135 | myeloid dendritic cell activation (GO:0001773) | 2.48915961 |
| 136 | regulation of mast cell activation (GO:0033003) | 2.48551468 |
| 137 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.43102916 |
| 138 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.40426540 |
| 139 | regulation of interleukin-2 production (GO:0032663) | 2.39871584 |
| 140 | radial glial cell differentiation (GO:0060019) | 2.39406277 |
| 141 | positive regulation of metanephros development (GO:0072216) | 2.38448809 |
| 142 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.35922468 |
| 143 | germinal center formation (GO:0002467) | 2.33004413 |
| 144 | positive regulation of DNA recombination (GO:0045911) | 2.29996405 |
| 145 | T cell differentiation (GO:0030217) | 2.28715423 |
| 146 | regulation of T cell tolerance induction (GO:0002664) | 2.28531540 |
| 147 | alpha-beta T cell activation (GO:0046631) | 2.27247641 |
| 148 | Notch signaling involved in heart development (GO:0061314) | 2.26971644 |
| 149 | regulation of chronic inflammatory response (GO:0002676) | 2.26584009 |
| 150 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.25178719 |
| 151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.25178719 |
| 152 | regulation of heat generation (GO:0031650) | 2.25175150 |
| 153 | regulation of thymocyte apoptotic process (GO:0070243) | 2.24932264 |
| 154 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.24310528 |
| 155 | regulation of interleukin-4 production (GO:0032673) | 2.23184525 |
| 156 | positive regulation by symbiont of host defense response (GO:0052509) | 2.22735844 |
| 157 | modulation by symbiont of host defense response (GO:0052031) | 2.22735844 |
| 158 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.22735844 |
| 159 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.22735844 |
| 160 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.22735844 |
| 161 | modulation by symbiont of host immune response (GO:0052553) | 2.22735844 |
| 162 | face development (GO:0060324) | 2.21272890 |
| 163 | trophoblast giant cell differentiation (GO:0060707) | 2.21216397 |
| 164 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.19984194 |
| 165 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.19873270 |
| 166 | positive regulation of B cell mediated immunity (GO:0002714) | 2.19873270 |
| 167 | cellular response to gonadotropin stimulus (GO:0071371) | 2.18700680 |
| 168 | germ cell migration (GO:0008354) | 2.17324599 |
| 169 | monocyte chemotaxis (GO:0002548) | 2.16744300 |
| 170 | histone H3-K4 methylation (GO:0051568) | 2.16660114 |
| 171 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.15848447 |
| 172 | regulation of monocyte differentiation (GO:0045655) | 2.15019339 |
| 173 | negative regulation of myoblast differentiation (GO:0045662) | 2.13376412 |
| 174 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.12778868 |
| 175 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.12778868 |
| 176 | regulation of interleukin-12 production (GO:0032655) | 2.12285563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.85150271 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.38613315 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.24059515 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.09847682 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.45736081 |
| 6 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.01816800 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.93619171 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.85337268 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.84199557 |
| 10 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.71434770 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.67383370 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.55594752 |
| 13 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.51382812 |
| 14 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.45251673 |
| 15 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.33203204 |
| 16 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.28390769 |
| 17 | * MYC_22102868_ChIP-Seq_BL_Human | 2.28073105 |
| 18 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.20004799 |
| 19 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.19309073 |
| 20 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.19309073 |
| 21 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.19309073 |
| 22 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.17752013 |
| 23 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.08173880 |
| 24 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.07066748 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04892362 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.04372920 |
| 27 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.02422211 |
| 28 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.01238426 |
| 29 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.92354826 |
| 30 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.91483789 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.91482832 |
| 32 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.88307224 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82688787 |
| 34 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.78759392 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.78681866 |
| 36 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78302958 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.77104238 |
| 38 | * MAF_26560356_Chip-Seq_TH1_Human | 1.74480944 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72477506 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.72313595 |
| 41 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.65101378 |
| 42 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64764756 |
| 43 | * STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63608438 |
| 44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.63005291 |
| 45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.62112837 |
| 46 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.60132386 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.57695705 |
| 48 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.57041760 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.55687849 |
| 50 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.55383536 |
| 51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.52810195 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.50083598 |
| 53 | * MYB_26560356_Chip-Seq_TH2_Human | 1.49758666 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49196887 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.48176558 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.47846805 |
| 57 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.44959361 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.44825796 |
| 59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42193790 |
| 60 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.41472476 |
| 61 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.39882075 |
| 62 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.39009076 |
| 63 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32887597 |
| 64 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31504220 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.31118107 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30929562 |
| 67 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.28877530 |
| 68 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.27462855 |
| 69 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27133731 |
| 70 | * MAF_26560356_Chip-Seq_TH2_Human | 1.26140646 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26061633 |
| 72 | * MYB_26560356_Chip-Seq_TH1_Human | 1.24730479 |
| 73 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23124113 |
| 74 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21917115 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18322741 |
| 76 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.17442277 |
| 77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17046393 |
| 78 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15797206 |
| 79 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.13639086 |
| 80 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13548963 |
| 81 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.12475123 |
| 82 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.11690477 |
| 83 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11648087 |
| 84 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10960626 |
| 85 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.10682224 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10142685 |
| 87 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.09739059 |
| 88 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.09362817 |
| 89 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.08472314 |
| 90 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08400129 |
| 91 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.08193175 |
| 92 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07670984 |
| 93 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.06616915 |
| 94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06483516 |
| 95 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.04510645 |
| 96 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.04187066 |
| 97 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03886457 |
| 98 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03878048 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02563091 |
| 100 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.01459080 |
| 101 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00611781 |
| 102 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00439337 |
| 103 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00023775 |
| 104 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99507227 |
| 105 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.99249069 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.98538714 |
| 107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97902453 |
| 108 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97609990 |
| 109 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97609990 |
| 110 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.97306161 |
| 111 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97139534 |
| 112 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96450727 |
| 113 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.96400708 |
| 114 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96292945 |
| 115 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.95547331 |
| 116 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94921921 |
| 117 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94913462 |
| 118 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.94645150 |
| 119 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.94477245 |
| 120 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.94477245 |
| 121 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94404656 |
| 122 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94226636 |
| 123 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94100342 |
| 124 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.93308502 |
| 125 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92706683 |
| 126 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92126334 |
| 127 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.91895774 |
| 128 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91845892 |
| 129 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91773666 |
| 130 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91763923 |
| 131 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.91513661 |
| 132 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91492059 |
| 133 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.91065588 |
| 134 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.90973634 |
| 135 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90932611 |
| 136 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.90166412 |
| 137 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.89825727 |
| 138 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89600959 |
| 139 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89347338 |
| 140 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.89296354 |
| 141 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88246864 |
| 142 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88110013 |
| 143 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87961911 |
| 144 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.86928241 |
| 145 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84972065 |
| 146 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.84006146 |
| 147 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83142522 |
| 148 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.82417326 |
| 149 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81531142 |
| 150 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.81157917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.54654619 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.24774717 |
| 3 | MP0004510_myositis | 3.10462455 |
| 4 | MP0003724_increased_susceptibility_to | 2.65531621 |
| 5 | MP0003436_decreased_susceptibility_to | 2.46919630 |
| 6 | MP0009278_abnormal_bone_marrow | 2.42304173 |
| 7 | MP0004381_abnormal_hair_follicle | 2.40777156 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.24052349 |
| 9 | MP0002405_respiratory_system_inflammati | 2.22369179 |
| 10 | MP0000685_abnormal_immune_system | 2.17473302 |
| 11 | MP0005387_immune_system_phenotype | 2.16523783 |
| 12 | MP0001790_abnormal_immune_system | 2.16523783 |
| 13 | MP0006082_CNS_inflammation | 2.15126397 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.02377566 |
| 15 | MP0005451_abnormal_body_composition | 2.02121794 |
| 16 | MP0001851_eye_inflammation | 1.92429270 |
| 17 | MP0002277_abnormal_respiratory_mucosa | 1.87129663 |
| 18 | MP0001853_heart_inflammation | 1.83405203 |
| 19 | MP0003172_abnormal_lysosome_physiology | 1.82362064 |
| 20 | MP0001800_abnormal_humoral_immune | 1.82298266 |
| 21 | MP0003866_abnormal_defecation | 1.81042865 |
| 22 | MP0008260_abnormal_autophagy | 1.76638389 |
| 23 | MP0002933_joint_inflammation | 1.75300351 |
| 24 | MP0005076_abnormal_cell_differentiation | 1.73485365 |
| 25 | MP0005671_abnormal_response_to | 1.73276261 |
| 26 | MP0008995_early_reproductive_senescence | 1.70236554 |
| 27 | MP0008961_abnormal_basal_metabolism | 1.69383561 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.67038800 |
| 29 | MP0008004_abnormal_stomach_pH | 1.66073709 |
| 30 | MP0002723_abnormal_immune_serum | 1.65976483 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.64406683 |
| 32 | MP0009764_decreased_sensitivity_to | 1.63520372 |
| 33 | MP0004742_abnormal_vestibular_system | 1.63178541 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.57204885 |
| 35 | MP0003828_pulmonary_edema | 1.55726921 |
| 36 | MP0000703_abnormal_thymus_morphology | 1.50634714 |
| 37 | * MP0002420_abnormal_adaptive_immunity | 1.45190075 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.43489779 |
| 39 | * MP0001819_abnormal_immune_cell | 1.43171007 |
| 40 | MP0005310_abnormal_salivary_gland | 1.42333747 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.42026308 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.39067716 |
| 43 | MP0002132_abnormal_respiratory_system | 1.38904740 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.37729522 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.35163429 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.35030387 |
| 47 | MP0004808_abnormal_hematopoietic_stem | 1.33781092 |
| 48 | MP0002398_abnormal_bone_marrow | 1.32628694 |
| 49 | MP0000049_abnormal_middle_ear | 1.32324070 |
| 50 | MP0008469_abnormal_protein_level | 1.32039828 |
| 51 | MP0004947_skin_inflammation | 1.30674284 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.30483811 |
| 53 | MP0002009_preneoplasia | 1.30142665 |
| 54 | MP0003075_altered_response_to | 1.29376986 |
| 55 | MP0000858_altered_metastatic_potential | 1.24291429 |
| 56 | MP0009840_abnormal_foam_cell | 1.23968021 |
| 57 | MP0001835_abnormal_antigen_presentation | 1.23130216 |
| 58 | MP0005423_abnormal_somatic_nervous | 1.23109530 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.20818075 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.20733319 |
| 61 | MP0005390_skeleton_phenotype | 1.20508297 |
| 62 | MP0002419_abnormal_innate_immunity | 1.19471087 |
| 63 | MP0000716_abnormal_immune_system | 1.18131603 |
| 64 | MP0005257_abnormal_intraocular_pressure | 1.17347286 |
| 65 | MP0009785_altered_susceptibility_to | 1.16879258 |
| 66 | MP0000383_abnormal_hair_follicle | 1.16463076 |
| 67 | MP0005058_abnormal_lysosome_morphology | 1.15814511 |
| 68 | MP0005409_darkened_coat_color | 1.14696689 |
| 69 | * MP0005025_abnormal_response_to | 1.13991327 |
| 70 | MP0002006_tumorigenesis | 1.10523977 |
| 71 | MP0005166_decreased_susceptibility_to | 1.09035718 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 1.06665690 |
| 73 | MP0004858_abnormal_nervous_system | 1.06240288 |
| 74 | MP0003385_abnormal_body_wall | 1.05475782 |
| 75 | MP0001340_abnormal_eyelid_morphology | 1.05092669 |
| 76 | MP0002722_abnormal_immune_system | 1.04233714 |
| 77 | MP0003448_altered_tumor_morphology | 1.03836414 |
| 78 | MP0005164_abnormal_response_to | 1.02686125 |
| 79 | MP0010030_abnormal_orbit_morphology | 1.01331996 |
| 80 | MP0005508_abnormal_skeleton_morphology | 1.01242285 |
| 81 | MP0001879_abnormal_lymphatic_vessel | 1.01165967 |
| 82 | MP0004883_abnormal_blood_vessel | 1.00348191 |
| 83 | MP0000689_abnormal_spleen_morphology | 0.99147287 |
| 84 | MP0002249_abnormal_larynx_morphology | 0.98198766 |
| 85 | MP0003705_abnormal_hypodermis_morpholog | 0.96931000 |
| 86 | MP0003136_yellow_coat_color | 0.96552040 |
| 87 | MP0002332_abnormal_exercise_endurance | 0.95656286 |
| 88 | MP0000767_abnormal_smooth_muscle | 0.95481707 |
| 89 | MP0003938_abnormal_ear_development | 0.95298375 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.94439615 |
| 91 | MP0001663_abnormal_digestive_system | 0.94412366 |
| 92 | MP0000604_amyloidosis | 0.93251305 |
| 93 | MP0001348_abnormal_lacrimal_gland | 0.92967802 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.92806062 |
| 95 | MP0001873_stomach_inflammation | 0.92193146 |
| 96 | MP0003941_abnormal_skin_development | 0.91981681 |
| 97 | MP0000566_synostosis | 0.91853222 |
| 98 | MP0001545_abnormal_hematopoietic_system | 0.90523529 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 0.90523529 |
| 100 | MP0003690_abnormal_glial_cell | 0.90268846 |
| 101 | MP0003091_abnormal_cell_migration | 0.90089845 |
| 102 | MP0000733_abnormal_muscle_development | 0.89061439 |
| 103 | MP0002396_abnormal_hematopoietic_system | 0.86048456 |
| 104 | MP0002098_abnormal_vibrissa_morphology | 0.85911584 |
| 105 | MP0002116_abnormal_craniofacial_bone | 0.85794017 |
| 106 | MP0002429_abnormal_blood_cell | 0.85270844 |
| 107 | MP0003795_abnormal_bone_structure | 0.84285655 |
| 108 | MP0002925_abnormal_cardiovascular_devel | 0.81923308 |
| 109 | MP0001845_abnormal_inflammatory_respons | 0.81763699 |
| 110 | MP0002653_abnormal_ependyma_morphology | 0.81633164 |
| 111 | MP0005174_abnormal_tail_pigmentation | 0.81444791 |
| 112 | MP0001216_abnormal_epidermal_layer | 0.81158096 |
| 113 | MP0000432_abnormal_head_morphology | 0.79936176 |
| 114 | MP0003755_abnormal_palate_morphology | 0.79754582 |
| 115 | MP0009250_abnormal_appendicular_skeleto | 0.77595619 |
| 116 | MP0002751_abnormal_autonomic_nervous | 0.77449432 |
| 117 | MP0001243_abnormal_dermal_layer | 0.77230758 |
| 118 | MP0002254_reproductive_system_inflammat | 0.76289733 |
| 119 | MP0008789_abnormal_olfactory_epithelium | 0.76084685 |
| 120 | MP0009379_abnormal_foot_pigmentation | 0.75762029 |
| 121 | MP0002282_abnormal_trachea_morphology | 0.75121987 |
| 122 | MP0000249_abnormal_blood_vessel | 0.74886578 |
| 123 | MP0005075_abnormal_melanosome_morpholog | 0.74750156 |
| 124 | MP0003045_fibrosis | 0.74624575 |
| 125 | MP0008057_abnormal_DNA_replication | 0.74518570 |
| 126 | MP0002697_abnormal_eye_size | 0.74250503 |
| 127 | MP0000343_altered_response_to | 0.73669918 |
| 128 | MP0005248_abnormal_Harderian_gland | 0.73412216 |
| 129 | MP0003935_abnormal_craniofacial_develop | 0.72864412 |
| 130 | MP0000613_abnormal_salivary_gland | 0.71816740 |
| 131 | MP0002060_abnormal_skin_morphology | 0.71355317 |
| 132 | MP0009765_abnormal_xenobiotic_induced | 0.71159551 |
| 133 | MP0001286_abnormal_eye_development | 0.69970590 |
| 134 | MP0009763_increased_sensitivity_to | 0.67937991 |
| 135 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66613339 |
| 136 | MP0005535_abnormal_body_temperature | 0.61031771 |
| 137 | MP0005666_abnormal_adipose_tissue | 0.60877441 |
| 138 | MP0004130_abnormal_muscle_cell | 0.60298589 |
| 139 | MP0005381_digestive/alimentary_phenotyp | 0.57860334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 6.08795556 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.69270774 |
| 3 | Abnormality of macrophages (HP:0004311) | 4.65305541 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.91195822 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.89802053 |
| 6 | Increased density of long bones (HP:0006392) | 3.78789678 |
| 7 | Persistence of primary teeth (HP:0006335) | 3.78008185 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.27523881 |
| 9 | Abnormality of the fingertips (HP:0001211) | 3.26081245 |
| 10 | Keratoconjunctivitis (HP:0001096) | 3.21442647 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.15171997 |
| 12 | Abnormality of the nasal septum (HP:0000419) | 2.98247949 |
| 13 | Recurrent skin infections (HP:0001581) | 2.95020943 |
| 14 | Encephalitis (HP:0002383) | 2.93168855 |
| 15 | Severe combined immunodeficiency (HP:0004430) | 2.89577605 |
| 16 | Urticaria (HP:0001025) | 2.84709061 |
| 17 | Cellulitis (HP:0100658) | 2.83434617 |
| 18 | Episodic fever (HP:0001954) | 2.83211552 |
| 19 | Lip pit (HP:0100267) | 2.83192163 |
| 20 | Amyloidosis (HP:0011034) | 2.79017295 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 2.68350057 |
| 22 | Prolonged bleeding time (HP:0003010) | 2.65635997 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 2.65402583 |
| 24 | Optic neuritis (HP:0100653) | 2.65402583 |
| 25 | Depressed nasal tip (HP:0000437) | 2.65156334 |
| 26 | Upper limb muscle weakness (HP:0003484) | 2.63531999 |
| 27 | Increased IgM level (HP:0003496) | 2.61456853 |
| 28 | Orchitis (HP:0100796) | 2.58679903 |
| 29 | Aplasia cutis congenita (HP:0001057) | 2.57824458 |
| 30 | Pulmonary artery stenosis (HP:0004415) | 2.55054561 |
| 31 | Ulnar claw (HP:0001178) | 2.47556498 |
| 32 | Leukocytosis (HP:0001974) | 2.46224867 |
| 33 | Peripheral hypomyelination (HP:0007182) | 2.45407050 |
| 34 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.43880304 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.36124147 |
| 36 | Myositis (HP:0100614) | 2.35252896 |
| 37 | Parakeratosis (HP:0001036) | 2.34638404 |
| 38 | Anhidrosis (HP:0000970) | 2.34202230 |
| 39 | Hypochromic anemia (HP:0001931) | 2.33852128 |
| 40 | Recurrent viral infections (HP:0004429) | 2.32761267 |
| 41 | Supernumerary ribs (HP:0005815) | 2.31625111 |
| 42 | Pulmonary embolism (HP:0002204) | 2.29835385 |
| 43 | Sparse lateral eyebrow (HP:0005338) | 2.29297609 |
| 44 | Gangrene (HP:0100758) | 2.28551321 |
| 45 | Inflammation of the large intestine (HP:0002037) | 2.27149882 |
| 46 | Gastrointestinal inflammation (HP:0004386) | 2.26927953 |
| 47 | Combined immunodeficiency (HP:0005387) | 2.25659434 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 2.24292560 |
| 49 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.23060184 |
| 50 | Autoimmune thrombocytopenia (HP:0001973) | 2.21035945 |
| 51 | Hypochromic microcytic anemia (HP:0004840) | 2.20319301 |
| 52 | Abnormality of the pleura (HP:0002103) | 2.17475205 |
| 53 | Anorexia (HP:0002039) | 2.15099073 |
| 54 | Epistaxis (HP:0000421) | 2.14306045 |
| 55 | Gingival bleeding (HP:0000225) | 2.13367378 |
| 56 | Submucous cleft hard palate (HP:0000176) | 2.11384618 |
| 57 | Abnormality of eosinophils (HP:0001879) | 2.10703121 |
| 58 | Gastrointestinal stroma tumor (HP:0100723) | 2.10562876 |
| 59 | Oligodontia (HP:0000677) | 2.08665165 |
| 60 | Hypergammaglobulinemia (HP:0010702) | 2.08582611 |
| 61 | Slow saccadic eye movements (HP:0000514) | 2.07167875 |
| 62 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.06861302 |
| 63 | Sepsis (HP:0100806) | 2.06780867 |
| 64 | Eosinophilia (HP:0001880) | 2.06533879 |
| 65 | Thick nail (HP:0001805) | 2.06432244 |
| 66 | Somatic mutation (HP:0001428) | 2.06029949 |
| 67 | Abnormality of the endocardium (HP:0004306) | 2.03496205 |
| 68 | Panhypogammaglobulinemia (HP:0003139) | 2.02845490 |
| 69 | Loss of speech (HP:0002371) | 2.02700910 |
| 70 | Rib fusion (HP:0000902) | 2.02080475 |
| 71 | Midline defect of the nose (HP:0004122) | 2.01976738 |
| 72 | Restrictive lung disease (HP:0002091) | 2.01770972 |
| 73 | Osteomyelitis (HP:0002754) | 2.01521226 |
| 74 | Increased cerebral lipofuscin (HP:0011813) | 2.01159634 |
| 75 | Acne (HP:0001061) | 2.00828803 |
| 76 | Intestinal fistula (HP:0100819) | 2.00683769 |
| 77 | Lymphopenia (HP:0001888) | 2.00166538 |
| 78 | Onion bulb formation (HP:0003383) | 1.97809156 |
| 79 | Colitis (HP:0002583) | 1.96753532 |
| 80 | Chin dimple (HP:0010751) | 1.94409351 |
| 81 | Gastrointestinal infarctions (HP:0005244) | 1.92353662 |
| 82 | Pulmonary infiltrates (HP:0002113) | 1.91839064 |
| 83 | T lymphocytopenia (HP:0005403) | 1.89883416 |
| 84 | Vasculitis (HP:0002633) | 1.89763195 |
| 85 | Chronic obstructive pulmonary disease (HP:0006510) | 1.88530550 |
| 86 | Obstructive lung disease (HP:0006536) | 1.88530550 |
| 87 | Abnormality of the intervertebral disk (HP:0005108) | 1.87755594 |
| 88 | Glomerulopathy (HP:0100820) | 1.87517883 |
| 89 | Emphysema (HP:0002097) | 1.86532261 |
| 90 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.85859026 |
| 91 | Vertigo (HP:0002321) | 1.84647568 |
| 92 | Abnormality of T cells (HP:0002843) | 1.84365825 |
| 93 | Spinal cord lesions (HP:0100561) | 1.83866007 |
| 94 | Syringomyelia (HP:0003396) | 1.83866007 |
| 95 | Increased serum ferritin (HP:0003281) | 1.83832187 |
| 96 | Abnormality of the peritoneum (HP:0002585) | 1.82671857 |
| 97 | Abnormality of T cell number (HP:0011839) | 1.81238112 |
| 98 | Disproportionate tall stature (HP:0001519) | 1.81131813 |
| 99 | Abnormality of the pericardium (HP:0001697) | 1.80798536 |
| 100 | Stomach cancer (HP:0012126) | 1.80268240 |
| 101 | Subacute progressive viral hepatitis (HP:0006572) | 1.78525860 |
| 102 | Nasal polyposis (HP:0100582) | 1.78418190 |
| 103 | Gingivitis (HP:0000230) | 1.78290649 |
| 104 | Spontaneous hematomas (HP:0007420) | 1.78278923 |
| 105 | Hemoptysis (HP:0002105) | 1.77578159 |
| 106 | Anal stenosis (HP:0002025) | 1.76427024 |
| 107 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.75854493 |
| 108 | Broad face (HP:0000283) | 1.75610704 |
| 109 | Increased CSF protein (HP:0002922) | 1.75589358 |
| 110 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.75425802 |
| 111 | Long eyelashes (HP:0000527) | 1.74177783 |
| 112 | Trigonocephaly (HP:0000243) | 1.72920711 |
| 113 | Thin bony cortex (HP:0002753) | 1.72830890 |
| 114 | Joint swelling (HP:0001386) | 1.72619336 |
| 115 | Alveolar cell carcinoma (HP:0006519) | 1.71468999 |
| 116 | Arthralgia (HP:0002829) | 1.71269657 |
| 117 | Abnormality of glycolipid metabolism (HP:0010969) | 1.71204296 |
| 118 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.71204296 |
| 119 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.71204296 |
| 120 | Periauricular skin pits (HP:0100277) | 1.69744581 |
| 121 | Preauricular pit (HP:0004467) | 1.69744581 |
| 122 | Keratitis (HP:0000491) | 1.69498137 |
| 123 | Malnutrition (HP:0004395) | 1.69012689 |
| 124 | Hypoplasia of the iris (HP:0007676) | 1.68679269 |
| 125 | Ureteral obstruction (HP:0006000) | 1.68575196 |
| 126 | Cheilitis (HP:0100825) | 1.68242832 |
| 127 | Obstructive sleep apnea (HP:0002870) | 1.67950674 |
| 128 | Abnormality of the columella (HP:0009929) | 1.67167306 |
| 129 | Recurrent cutaneous fungal infections (HP:0011370) | 1.66463868 |
| 130 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.66463868 |
| 131 | Ureteral stenosis (HP:0000071) | 1.64361721 |
| 132 | Concave nail (HP:0001598) | 1.64219313 |
| 133 | Absent hand (HP:0004050) | 1.61506337 |
| 134 | Abnormality of primary teeth (HP:0006481) | 1.60614486 |
| 135 | Abnormality of the parietal bone (HP:0002696) | 1.59161551 |
| 136 | Thyroiditis (HP:0100646) | 1.58777057 |
| 137 | Dislocated radial head (HP:0003083) | 1.57867031 |
| 138 | Abnormality of the radial head (HP:0003995) | 1.56223326 |
| 139 | Down-sloping shoulders (HP:0200021) | 1.55143310 |
| 140 | Morphological abnormality of the middle ear (HP:0008609) | 1.55100992 |
| 141 | Granulocytopenia (HP:0001913) | 1.54584227 |
| 142 | Increased IgE level (HP:0003212) | 1.53747751 |
| 143 | Recurrent abscess formation (HP:0002722) | 1.53692571 |
| 144 | Long palpebral fissure (HP:0000637) | 1.53520446 |
| 145 | Premature loss of primary teeth (HP:0006323) | 1.51926903 |
| 146 | Pustule (HP:0200039) | 1.50705699 |
| 147 | IgA deficiency (HP:0002720) | 1.49908292 |
| 148 | Meningitis (HP:0001287) | 1.49597638 |
| 149 | Keratoconjunctivitis sicca (HP:0001097) | 1.46691295 |
| 150 | Progressive sensorineural hearing impairment (HP:0000408) | 1.45744984 |
| 151 | Septate vagina (HP:0001153) | 1.44549934 |
| 152 | Chest pain (HP:0100749) | 1.44199151 |
| 153 | Premature skin wrinkling (HP:0100678) | 1.43996190 |
| 154 | Narrow palate (HP:0000189) | 1.43716887 |
| 155 | Arterial thrombosis (HP:0004420) | 1.43668683 |
| 156 | Large earlobe (HP:0009748) | 1.43087268 |
| 157 | Skin pits (HP:0100276) | 1.42968459 |
| 158 | Anteriorly placed anus (HP:0001545) | 1.41939452 |
| 159 | Progressive hearing impairment (HP:0001730) | 1.41878912 |
| 160 | Peritonitis (HP:0002586) | 1.41174890 |
| 161 | Laryngomalacia (HP:0001601) | 1.40825339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 3.48643673 |
| 2 | RIPK4 | 3.41339223 |
| 3 | CDK12 | 3.17259927 |
| 4 | MAP4K1 | 3.01400539 |
| 5 | MAP3K14 | 2.91044070 |
| 6 | CHUK | 2.54300192 |
| 7 | MKNK2 | 2.36586662 |
| 8 | EPHB1 | 2.33264451 |
| 9 | MAPK15 | 2.31980005 |
| 10 | IKBKB | 2.24598038 |
| 11 | PIM2 | 2.21996809 |
| 12 | NLK | 2.17717673 |
| 13 | BLK | 2.08640737 |
| 14 | TRIB3 | 2.06913925 |
| 15 | EPHA3 | 1.80126217 |
| 16 | IRAK3 | 1.74144998 |
| 17 | MAP3K10 | 1.73465918 |
| 18 | TNK2 | 1.70184588 |
| 19 | MKNK1 | 1.64446648 |
| 20 | IKBKE | 1.64012454 |
| 21 | PIM1 | 1.57863973 |
| 22 | BRD4 | 1.57396329 |
| 23 | ZAP70 | 1.57379786 |
| 24 | ITK | 1.56987863 |
| 25 | MAP3K1 | 1.41983704 |
| 26 | IRAK4 | 1.41109378 |
| 27 | CSK | 1.38530892 |
| 28 | TGFBR2 | 1.37045316 |
| 29 | MAP3K13 | 1.36915793 |
| 30 | PRPF4B | 1.32702679 |
| 31 | MAP3K3 | 1.29256745 |
| 32 | CLK1 | 1.28840390 |
| 33 | TBK1 | 1.27777115 |
| 34 | RPS6KA5 | 1.27500428 |
| 35 | IRAK1 | 1.20571764 |
| 36 | CDC42BPA | 1.17757103 |
| 37 | DMPK | 1.16876775 |
| 38 | MARK2 | 1.16593470 |
| 39 | TAOK1 | 1.16458446 |
| 40 | SIK2 | 1.14530137 |
| 41 | SMG1 | 1.13980371 |
| 42 | JAK3 | 1.11655229 |
| 43 | ICK | 1.10714303 |
| 44 | KSR2 | 1.09438377 |
| 45 | HIPK2 | 1.08702156 |
| 46 | JAK2 | 1.06663660 |
| 47 | TEC | 1.06485063 |
| 48 | STK10 | 1.04971833 |
| 49 | SIK3 | 1.04361244 |
| 50 | MAP3K11 | 1.03886682 |
| 51 | MATK | 1.02561181 |
| 52 | MST4 | 1.01242787 |
| 53 | JAK1 | 0.99605281 |
| 54 | HCK | 0.98303823 |
| 55 | SYK | 0.98161119 |
| 56 | MUSK | 0.93362740 |
| 57 | GSK3A | 0.93312181 |
| 58 | PTK6 | 0.92293707 |
| 59 | NUAK1 | 0.88891589 |
| 60 | TAOK3 | 0.88777968 |
| 61 | LYN | 0.87424140 |
| 62 | TAOK2 | 0.87235986 |
| 63 | LCK | 0.87136257 |
| 64 | RPS6KA1 | 0.86401213 |
| 65 | RPS6KA4 | 0.86365980 |
| 66 | BTK | 0.83398024 |
| 67 | TNIK | 0.83164803 |
| 68 | EPHB2 | 0.82090807 |
| 69 | FES | 0.79989028 |
| 70 | PDGFRB | 0.79399737 |
| 71 | BMX | 0.79105355 |
| 72 | MAP2K2 | 0.76794575 |
| 73 | IRAK2 | 0.76469732 |
| 74 | CDK9 | 0.75909226 |
| 75 | SGK3 | 0.71820702 |
| 76 | PRKD2 | 0.70754706 |
| 77 | PDK1 | 0.70631020 |
| 78 | PAK2 | 0.70546434 |
| 79 | PDPK1 | 0.68842128 |
| 80 | DYRK1B | 0.68607149 |
| 81 | UHMK1 | 0.67445300 |
| 82 | MAPK12 | 0.67400550 |
| 83 | CSF1R | 0.64122564 |
| 84 | FGFR3 | 0.63456714 |
| 85 | PKN2 | 0.62238235 |
| 86 | GRK6 | 0.61939763 |
| 87 | YES1 | 0.61424173 |
| 88 | SIK1 | 0.61305722 |
| 89 | WNK1 | 0.61098030 |
| 90 | PKN1 | 0.60943935 |
| 91 | BMPR2 | 0.60496927 |
| 92 | MTOR | 0.60048604 |
| 93 | CAMK1D | 0.59979941 |
| 94 | MAP2K3 | 0.59622581 |
| 95 | MAPKAPK2 | 0.59143641 |
| 96 | RPS6KA2 | 0.58888685 |
| 97 | RPS6KA6 | 0.58809249 |
| 98 | CAMK4 | 0.58616964 |
| 99 | MAP3K6 | 0.58113371 |
| 100 | SGK2 | 0.57955211 |
| 101 | TGFBR1 | 0.57602337 |
| 102 | EIF2AK2 | 0.56968307 |
| 103 | FGFR4 | 0.56033254 |
| 104 | CAMKK1 | 0.55944161 |
| 105 | MARK3 | 0.55775585 |
| 106 | DYRK2 | 0.54855862 |
| 107 | TYRO3 | 0.54689468 |
| 108 | FGR | 0.54213226 |
| 109 | BMPR1B | 0.53456492 |
| 110 | MAP3K7 | 0.51658407 |
| 111 | LATS1 | 0.50144409 |
| 112 | KIT | 0.49756425 |
| 113 | DDR2 | 0.49667450 |
| 114 | EEF2K | 0.48544574 |
| 115 | STK11 | 0.47584109 |
| 116 | MELK | 0.47256691 |
| 117 | NTRK2 | 0.46989444 |
| 118 | RET | 0.46587374 |
| 119 | TYK2 | 0.46403461 |
| 120 | CAMK1G | 0.46119482 |
| 121 | RPS6KL1 | 0.46033911 |
| 122 | RPS6KC1 | 0.46033911 |
| 123 | GRK7 | 0.45911083 |
| 124 | FYN | 0.45610962 |
| 125 | MAPK7 | 0.44101806 |
| 126 | CDK3 | 0.43891838 |
| 127 | INSR | 0.43797909 |
| 128 | LRRK2 | 0.43618886 |
| 129 | ERN1 | 0.43344622 |
| 130 | MAP3K5 | 0.43191472 |
| 131 | PNCK | 0.42529071 |
| 132 | ABL1 | 0.42190976 |
| 133 | RIPK1 | 0.41868684 |
| 134 | EPHA2 | 0.41048267 |
| 135 | MAP3K2 | 0.41021607 |
| 136 | SRPK1 | 0.40787326 |
| 137 | PRKCZ | 0.38589444 |
| 138 | SGK494 | 0.38052589 |
| 139 | SGK223 | 0.38052589 |
| 140 | STK38 | 0.37585298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.66111704 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.57361199 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.23925095 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.07221418 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.02008296 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85222567 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.85043763 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.78369748 |
| 9 | Asthma_Homo sapiens_hsa05310 | 1.77116207 |
| 10 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.72383072 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.70070283 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.69969276 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.69439969 |
| 14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.68037393 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.64540890 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63887557 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.58313656 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.57470239 |
| 19 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.57154150 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.56377351 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47064042 |
| 22 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.46310054 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.45538629 |
| 24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.39792438 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36554999 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31440797 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.30555537 |
| 28 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.29773678 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.27823600 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27224926 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.24257391 |
| 32 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.22628257 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.21582486 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.20507183 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.18550845 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.16900143 |
| 37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15834305 |
| 38 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.15763785 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15073913 |
| 40 | HTLV-I infection_Homo sapiens_hsa05166 | 1.11429743 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09434989 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.06395964 |
| 43 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.04436478 |
| 44 | Prostate cancer_Homo sapiens_hsa05215 | 1.02350168 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 0.98654753 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98349218 |
| 47 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.97964870 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97472653 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.97381297 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 0.96908441 |
| 51 | Adherens junction_Homo sapiens_hsa04520 | 0.95864401 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95111286 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94125066 |
| 54 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.92425153 |
| 55 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.91596562 |
| 56 | Axon guidance_Homo sapiens_hsa04360 | 0.90805639 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90671515 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.90147595 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.89896058 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.88860350 |
| 61 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88432097 |
| 62 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.86891697 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.85373060 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84697812 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.84695601 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.84179256 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 0.83956327 |
| 68 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.82908124 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82848792 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82816972 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81975757 |
| 72 | Pathways in cancer_Homo sapiens_hsa05200 | 0.81493597 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81366555 |
| 74 | Ribosome_Homo sapiens_hsa03010 | 0.81073215 |
| 75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.78135459 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77946706 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77036485 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76109950 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75245834 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.75112005 |
| 81 | Spliceosome_Homo sapiens_hsa03040 | 0.73397205 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.73281212 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73165259 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72461322 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72396744 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71606517 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71566941 |
| 88 | Tuberculosis_Homo sapiens_hsa05152 | 0.70216407 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69938255 |
| 90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69890839 |
| 91 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.69288455 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.68251416 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.66005108 |
| 94 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.65722023 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65643350 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65492391 |
| 97 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.64609352 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63615373 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.61103962 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60858887 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60758689 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60666421 |
| 103 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60482655 |
| 104 | Lysosome_Homo sapiens_hsa04142 | 0.60474095 |
| 105 | Focal adhesion_Homo sapiens_hsa04510 | 0.60404551 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59626085 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59449138 |
| 108 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.59378539 |
| 109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57246667 |
| 110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57132269 |
| 111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56990351 |
| 112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56895037 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56651895 |
| 114 | Lysine degradation_Homo sapiens_hsa00310 | 0.56629631 |
| 115 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56057305 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55264996 |
| 117 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54999108 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54843055 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53699070 |
| 120 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53414415 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52507346 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51038698 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50344690 |
| 124 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49449772 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48600560 |
| 126 | Glioma_Homo sapiens_hsa05214 | 0.48157687 |
| 127 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45360668 |
| 128 | Insulin resistance_Homo sapiens_hsa04931 | 0.44659140 |
| 129 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44239642 |

